Advertisement

Topics

Latest "BioMarker Strategies LLC" News Stories

00:49 EST 22nd February 2019 | BioPortfolio

Here are the most relevant search results for "BioMarker Strategies LLC" found in our extensive news archives from over 250 global news sources.

More Information about BioMarker Strategies LLC on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioMarker Strategies LLC for you to read. Along with our medical data and news we also list BioMarker Strategies LLC Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioMarker Strategies LLC Companies for you to search.

Showing "BioMarker Strategies" News Articles 1–25 of 8,500+

Thursday 21st February 2019

AdipoGen PD-1/PD-L1 ELISA Kits

AdipoGen has released PD-1/PD-L1 (Programmed Cell Death Protein-1/Programmed Cell Death Ligand-1) ELISA Kits for the detection of PD-1 and PD-L1 in biological fluids. Regulation and activation of T lymphocytes depend on signalling by the T cell receptor (TCR) and also by co-signalling receptors that deliver negative or positive signals. The PD-1/PD-L1 signalling pathway is a negative regulatory m...


Covalon Announces Conference Call to Discuss First Quarter Financial Results

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will be releasing its Fiscal 2019 First Quarter financial results on Tuesday February 26th, 2019, after markets close. A conference call to discuss the financial results will be held Wednesday February 27th, 2019, ...

Quanterix to Present at Multiple Upcoming Healthcare Conferences

Chief Executive Officer will speak at the Leerink Partners Global Healthcare Conference and the Cowen and Company Health Care Conference Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Kevin Hrusovsky, Chief Executive Officer, President and ...


Ultivue Expands Global Presence with Opening of European Subsidiary, Ultivue EMEA Srl

Ultivue, a developer of tissue biomarker identification and quantification assays for pathology and translational research labs, today announced that it has expanded its commercial footprint with a wholly-owned European subsidiary and appointed Luigi Pirovano as General Manager. Mr. Pirovano is an international executive with significant experience managin...

Bona Vida Announces Launch of Global CBD Platform and Simultaneous Close of Financing Round

Bona Vida, Inc. www.bonavida.com (“Bona Vida” or the “Company”) is excited to announce the launch of its global CBD platform, focused on developing a portfolio of brand and product verticals within the animal and adult health and wellness space. The Company will be exclusively focused on CBD derived from industrial hemp, with the goal of ...

ArQule to Present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Brian Schwartz, M.D., Chief Medical Officer and Head of Research and Development, of ArQule will present at the 8th Annual Leerink Partners Global Healthcare Conference on February 28, 2019, at 11:30 a.m. ET at the Lotte New York Palace in New York City. The...

ArQule to Report Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019

ArQule, Inc. (Nasdaq: ARQL) today announced it will report financial results for the fourth quarter and full year of 2018 before the market opens on Thursday, March 7, 2019. The Company will hold a conference call and webcast on the same day at 9:00 a.m. ET to discuss these results and provide a general business update. The live webcast can be acc...

Trump Plan To Beat HIV Hits Rough Road In Rural America

Health officials and doctors treating patients with HIV welcome the funding push, but warn that the strategies that work in progressive cities don't necessarily translate to rural areas.

News & Views: Researchers are coming up with new strategies to combat stress-related illness using a combination of state-of-the-art neuroscience techniques and a creative behavioural assay in mice, according to a Nature paper. https://go.nature.com/2N9VF

News & Views: Researchers are coming up with new strategies to combat stress-related illness using a combination of state-of-the-art neuroscience techniques and a creative behavioural assay in mice, according to a Nature paper. https://go.nature.com/2N9VFIW 

Crescent European Specialty Lending Announces Financing for AIO II, Holding Company of The Netherlands-Based Pharmacy Chain Medsen and Compounding Pharmacy Ceban

Crescent Capital Group LP, a leading alternative credit investment firm, announced today that its European Specialty Lending strategy has provided financing to support the acquisition of AIO II by funds managed by Bencis Capital Partners and management. Crescent is also providing financing to support AIO II’s ongoing buy and build efforts. Terms of the t...

PureTech Health to Present at Two Upcoming Investor Conferences

PureTech Health plc (LSE: PRTC) (“PureTech Health”), an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) Axis, today announced two presentations at upcoming investor conferences. Daphne Zohar, co-founder and chief executive officer, will present at the SVB Leerink Global Healthcare Conf...

A data visualization of carbon footprints

A Columbia researcher affiliated with the Data Science Institute has created a data-visualization tool that shows the carbon footprints of hundreds of consumer products. The tool makes it easy for everyone to explore the products' carbon-emission levels and the various strategies that companies are ...

Wednesday 20th February 2019

Researchers at @GeorgiaTech and @EmoryUniversity develop a novel nanoparticle method that serves as a non-invasive biomarker of early transplant rejection: http://ow.ly/AV0230nLP9A 

Researchers at @GeorgiaTech and @EmoryUniversity develop a novel nanoparticle method that serves as a non-invasive biomarker of early transplant rejection: http://ow.ly/AV0230nLP9A 

Dental Management Strategies Acquired by Talisker Partners

Transitus capital serves as exclusive financial advisor to dental management strategies. DALLAS (PRWEB) February 20, 2019 Transitus Capital, a leading middle-market investment banking firm, is proud to announce that it served as the exclusive financial advisor to Dental Management Strategies, LLC (“DMS”) in the recent acquisition by Talisker Partners. Based in the Dallas/Ft. Worth metroplex, ...

PET scans show biomarkers could spare some breast cancer patients from chemotherapy

(Johns Hopkins Medicine) In an effort to further individualize therapy and avoid over-treating patients, researchers at the Johns Hopkins Kimmel Cancer Center report a new study using PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chem...

Acquired cow’s milk sensitization after liver transplant in an adult: “clinical implications” and future strategies

Identifying the mechanisms responsible for the development of food allergy in liver transplant recipients is more complex as there are several different clinical scenarios related to the immunological function...

Renowned Pharmaceutical R&D Expert Jan Lundberg Joins Metabolon’s Board of Directors

Metabolon, the world leader in metabolomics, today announced that Dr. Jan Lundberg, Ph.D. has joined its Board of Directors. Dr. Lundberg brings significant experience leading large global research and development organizations, most recently as President of Lilly Research Labs and Head of R&D at Eli Lilly. Lundberg will serve as an independent directo...

Peripheral perfusion-targeted resuscitation does not lower mortality in septic shock patients

1. In this randomized controlled trial, there was no difference in 28-day mortality in patients with early septic shock between peripheral perfusion-targeted resuscitation and lactate level-target resuscitation strategies. 2. There was significantly less organ dysfunction at 72 hours in the peripheral perfusion group. Evidence Rating Level: 2 (Good) Study Rundown: Early resuscitation helps fight m...

MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer

Glowing Urine Detects Organ Transplant Rejection

Early detection of transplant rejection is critically important to the successful outcome of the transplant and the long-term health of the patient. Now, a team of researchers has developed a novel nanoparticle method that makes urine glow as soon as T cells initiate an attack on transplanted organs, serving as a non-invasive biomarker of early […] The post Glowing Urine Detects Organ Transp...

Former Nestlé Innovation Head Valerio Nannini Joins Digital Health Company Savor Health

Savor Health is pleased to announce the addition of Valerio Nannini, former SVP, Head of Strategies and Performance at Nestle Global HQ NEW YORK (PRWEB) February 20, 2019 Savor Health is pleased to announce the addition of Valerio Nannini, former Senior Vice-President, head of Strategies and Performance at Nestlé global HQ, as a senior strategic advisor to the company. Nannini, who led Nestl...

ROKIT Healthcare Announces a Novel Application of Dermal Regeneration Platform Using Proprietary Three-Dimensional Bioprinting Strategy

Applications of the treatment will expand to different indications in need to regenerative therapeutic strategies, including scar removal, burns, and pressure/diabetic foot ulcers SEOUL, South Korea, Feb. 20, 2019 /PRNewswire/ -- ROKIT Healthcare, Inc., a regenerative medicine company focused on the development of novel regenerative therapeutic strategies using three-dimensional (3D) biofabricati...

Tuesday 19th February 2019

Spain MicroElectromechanical Sensors Market Outlook to 2025 [Report Updated: 01122018] Prices from USD $4995

Spain MicroElectromechanical Sensors Market Outlook to 2025SummaryGlobalData's new report, Spain MicroElectromechanical Sensors Market Outlook to 2025, provides key market data on the Spain MicroElectromechanical Sensors market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segment.The report also provides company shares and distribution...

Anti-#Cancer strategies equip the immune system to recognize (and rout) well-camouflaged foes: http://ow.ly/iMFk30nKWB0 

Anti- #Cancer strategies equip the immune system to recognize (and rout) well-camouflaged foes: http://ow.ly/iMFk30nKWB0 

Activating tooth regeneration in mice

(King's College London) Most reptiles and fish have multiple sets of teeth during their lifetime. However, most mammals, such as humans, have only one set of replacement teeth and some mammals, like mice, have only a single set with no replacement. This diversity raises both evolutionary questions -- how did different tooth replacement strategies evolve? -- and developmental ones -- which mechanis...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks